Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Luye Pharma Group Ltd.
  6. News
  7. Summary
    2186   BMG570071099

LUYE PHARMA GROUP LTD.

(2186)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Luye Pharma : Chinese Regulators Accept Luye Pharma's Marketing Authorization for Osteoporosis Biosimilar Treatment

10/13/2021 | 09:42pm EST


ę MT Newswires 2021
All news about LUYE PHARMA GROUP LTD.
11/26LUYE PHARMA : Boan Biotech Publishes Results of Anti-CD25 Antibody Research in Nature Sub-..
PU
11/24LUYE PHARMA : Boan Biotech Reaches Strategic Collaboration Agreement with Merck to Build I..
PU
11/16LUYE PHARMA : Holds Its First Middle East & North Africa Psychiatry Symposium
PU
11/15Luye Pharma Submits Investigational New Drug Application for Parkinson's Disease Treatm..
MT
11/15LUYE PHARMA : Innovative Long-acting Microspheres Injection LY03009 Soon to Begin Clinical..
PU
11/10Luye Pharma Grants Swiss Partner Exclusive Rights for Dementia Treatment in Switzerland
MT
10/28Chinese Regulators Approve Luye's Initiation of Clinical Trials for Parkinson's Disease..
MT
10/27Luye Pharma's Innovative Long-acting Microspheres Injection LY03009 for Treating Parkin..
PU
10/27Luye Pharma Group Ltd. Announces Approval Obtained for Initiating Clinical Trial for th..
CI
10/22LUYE PHARMA : to Pay $37 Million over Termination of Distribution Deal
MT
More news
Financials
Sales 2021 5 667 M 887 M 887 M
Net income 2021 876 M 137 M 137 M
Net Debt 2021 3 381 M 529 M 529 M
P/E ratio 2021 15,2x
Yield 2021 1,11%
Capitalization 12 997 M 1 666 M 2 035 M
EV / Sales 2021 2,89x
EV / Sales 2022 2,53x
Nbr of Employees 4 788
Free-Float 64,5%
Chart LUYE PHARMA GROUP LTD.
Duration : Period :
Luye Pharma Group Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LUYE PHARMA GROUP LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Last Close Price 3,67 CNY
Average target price 4,16 CNY
Spread / Average Target 13,3%
EPS Revisions
Managers and Directors
Dian Bo Liu Executive Chairman & Chief Executive Officer
Rong Bing Yang Vice Executive Chairman & President
Yuan Chong Liu Chief Financial Officer
You Xin Li Vice President, Head-Research & Development
Hua Qiao Zhang Independent Non-Executive Director